Our data was consistent with our expectation and contradicted Joseph et al.’s report, which analyzed invasive BC as a whole, as opposed to our study that specifically investigated the ER+/HER2− subtype based on the understanding that biology and characteristics are significantly different by subtypes. The gene discussed is ERBB2; the disease is breast cancer.